SCHEMBL9764769

SCHEMBL9764769

Cc1nc2cc3ccccc3cc2s1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.65
NPC1 O15118 4/20 0.65
RAB9A P51151 4/20 0.65
ALDH1A1 P00352 3/20 0.65
HSD17B10 Q99714 2/20 0.65
TP53 P04637 1/20 0.65
MAPT P10636 1/20 0.65
PKM P14618 1/20 0.65
HPGD P15428 1/20 0.65
GAA P10253 1/20 0.61
TDP1 Q9NUW8 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
KMT2A Q03164 3/20 0.49
PDE10A Q9Y233 1/20 0.49
HTT P42858 2/20 0.46
ALOX15 P16050 1/20 0.45
ATM Q13315 1/20 0.45
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44
LDHA P00338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384430 0.82 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL14588328 0.80 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL12635465 0.80 SMN1; SMN2 (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL18177599 0.79 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL14193958 0.76 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL55837 0.76 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL33272 0.76 GAA (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL30422583 0.76 GAA (1.00) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL3139327 0.75 PI4KA (0.58) SMN1; SMN2NPC1RAB9AALDH1A1HSD17B10
SCHEMBL20718749 0.75 KMT2A (0.49) SMN1; SMN2NPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819371-B Preparation method of benzothiazole-2-formaldehyde and derivatives thereof 新疆师范大学 2024-05-14 CN disclosed
CN-115819371-A Preparation method of benzothiazole-2-formaldehyde and derivatives thereof 新疆师范大学 2023-03-21 CN disclosed
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-30 US disclosed
EP-4006025-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-01 EP disclosed
US-11066537-B2 Composition, film, infrared cut filter, solid image pickup element, infrared sensor, camera module, and novel compound FUJIFILM CORPORATION (JP) 2021-07-20 US disclosed
US-20210095196-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-04-01 US disclosed
US-20180105957-A1 PROCESS FOR MAKING COMPOSITES COMPRISING RIGID-ROD POLYMERS AND GRAPHENE NANOPARTICLES DANG THUY D (US) 2018-04-19 US disclosed
US-9868977-B2 Red-shifted luciferins and methods of using same PROMEGA CORPORATION (US) 2018-01-16 US disclosed
US-9850596-B2 Composites comprising rigid-rod polymers and graphene nanoparticles and process for making the same TJC Polymer Inc. (US) 2017-12-26 US disclosed
US-20170314061-A1 NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2017-11-02 US disclosed
US-9732373-B2 Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence PROMEGA CORPORATION (US) 2017-08-15 US disclosed
US-20170002396-A1 RED-SHIFTED LUCIFERINS AND METHODS OF USING SAME JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2017-01-05 US disclosed
US-9447450-B2 Red-shifted luciferins and methods of using same PROMEGA CORPORATION (US) 2016-09-20 US disclosed
US-20160076079-A1 NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2016-03-17 US disclosed
US-20150218730-A1 COMPOSITES COMPRISING RIGID-ROD POLYMERS AND GRAPHENE NANOPARTICLES AND PROCESS FOR MAKING THE SAME DANG THUY D (US) 2015-08-06 US disclosed
US-20140304842-A1 RED-SHIFTED LUCIFERINS AND METHODS OF USING SAME PROMEGA CORPORATION (US) 2014-10-09 US disclosed
US-5053506-A PHotosensitive viricides EASTMAN KODAK COMPANY (US) 1991-10-01 US disclosed
US-4937344-A Novel sulfur-containing merocyanine dyes EASTMAN KODAK COMPANY (US) 1990-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002396-A1 RED-SHIFTED LUCIFERINS AND METHODS OF USING SAME GUSB, GLB1, MRPL21 SMN1; SMN2 4398/4885NPC1 844/4885RAB9A 1959/4885
US-20210095196-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES SSB, RO60, OSBP SMN1; SMN2 4645/4885NPC1 2361/4885RAB9A 428/4885
US-20140304842-A1 RED-SHIFTED LUCIFERINS AND METHODS OF USING SAME GUSB, GLB1, MRPL21 SMN1; SMN2 4398/4885NPC1 844/4885RAB9A 1959/4885
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME EML4, STOM, GJB2 SMN1; SMN2 2512/4885NPC1 3939/4885RAB9A 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.